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Abstract
Background: Although the control of ovarian production of steroid hormones is mainly of endocrine nature, there is
increasing evidence that the nervous system also influences ovarian steroidogenic output. The purpose of this work was
to study whether the celiac ganglion modulates, via the superior ovarian nerve, the anti-steroidogenic effect of LH in the
rat ovary. Using mid- and late-pregnant rats, we set up to study: 1) the influence of the noradrenergic stimulation of the
celiac ganglion on the ovarian production of the luteotropic hormone androstenedione; 2) the modulatory effect of
noradrenaline at the celiac ganglion on the anti-steroidogenic effect of LH in the ovary; and 3) the involvement of
catecholaminergic neurotransmitters released in the ovary upon the combination of noradrenergic stimulation of the celiac
ganglion and LH treatment of the ovary.
Methods: The ex vivo celiac ganglion-superior ovarian nerve-ovary integrated system was used. This model allows
studying in vitro how direct neural connections from the celiac ganglion regulate ovarian steroidogenic output. The system
was incubated in buffer solution with the ganglion and the ovary located in different compartments and linked by the
superior ovarian nerve. Three experiments were designed with the addition of: 1) noradrenaline in the ganglion
compartment; 2) LH in the ovarian compartment; and 3) noradrenaline and LH in the ganglion and ovarian compartments,
respectively. Rats of 15, 19, 20 and 21 days of pregnancy were used, and, as an end point, the concentration of the
luteotropic hormone androstenedione was measured in the ovarian compartment by RIA at various times of incubation.
For some of the experimental paradigms the concentration of various catecholamines (dihydroxyphenylalanine, dopamine,
noradrenaline and adrenaline) was also measured in the ovarian compartment by HPLC.
Results: The most relevant result concerning the action of noradrenaline in the celiac ganglion was found on day 21 of
pregnancy resulting in the inhibition of androstenedione release from the ovarian compartment. In addition on day 15 of
pregnancy, LH placed in the ovarian compartment led to an inhibition of the release of androstenedione, and this inhibitory
effect was further reinforced by the joint action of noradrenaline in the celiac ganglion and LH in the ovary. The levels of
catecholamines in the ovarian compartment showed differences among the experiments; of significance, the joint treatment
of noradrenaline in the celiac ganglion and LH in the ovary resulted in a remarkable increase in the ovarian levels of
noradrenaline and adrenaline when compared to the effect achieved by either one of the compounds added alone.
Conclusion: Our results demonstrate that the noradrenergic stimulation of the celiac ganglion reinforces the LH-induced
inhibition of androstenedione production by the ovary of late pregnant rats, and that this effect is associated with marked
changes in the release of catecholamines in the ovary.
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The ovary is innervated by the ovarian plexus nerve and
the superior ovarian nerve [1], the latter being the most
related to ovarian steroidogenesis [2]. Most of the fibers of
the superior ovarian nerve come from the postganglionic
sympathetic neurons of the celiac ganglion [3]. They
directly innervate the ovarian theca and secondary inter-
stitial cells and exert an indirect action on the luteal cells
[4]. Neurotransmitters of peptidergic and catecholaminer-
gic nature have been detected in the ovarian nervous ter-
minals of the superior ovarian nerve [5], some of which
are also present in the celiac ganglion [6]. Moreover, the
presence of intrinsic ovarian neurons in several mamma-
lian species, including rats, has been demonstrated [7-9].
Among the neurotransmitters expressed in these cells are
nitric oxide (NO), neuropeptide Y (NPY) and catecho-
lamines [10]. The celiac ganglion is part of the sympa-
thetic prevertebral chain possessing a great variety of
specific receptors and neurotransmitters such as catecho-
lamines, neuropeptides, and nitric oxide [3,11,12], and
constitutes a modulation center in the pathway of the
afferent and efferent fibers between the central nervous
system and the ovary [2]. The main preganglion neuro-
transmitter of the celiac ganglion is acetylcholine [13-15],
yet the celiac ganglion-mesenteric complex also contain α
and β adrenergic receptors and is innervated by fibers of
adrenergic nature that come from other preaortic ganglia
[6,16]. The presence of such receptors in the celiac gan-
glion has been demonstrated physiologically in adult
[17,18] and prepubertal rats [19].
Our laboratory has previously demonstrated that modifi-
cations in the adrenergic activity of the celiac ganglion
results in an altered capacity of the ovary of pregnant rats
to produce progesterone [17], suggesting that the celiac
ganglion-superior ovarian nerve-ovarian axis provides a
direct link between the autonomic nervous system and
the physiology of pregnancy (reviewed in [2]). More
recently, we have also shown that modifications in the
cholinergic input at the celiac ganglion also led, via the
superior ovarian nerve, to modifications in ovarian ster-
oidogenesis [20]. Adding a level of complexity to the
understanding of the neuroendocrine interactions
between the celiac ganglion and the physiology of the
ovary we showed that modifications in the hormonal
environment that surrounds the celiac ganglion affects its
behavior, ultimately affecting ovarian steroidogenesis
[2,21].
Androstenedione is a major luteotropic hormone for the
pregnant rat ovary. The involvement of androstenedione
is widely accepted in the maintenance of luteal function
upon its intraluteal conversion to estradiol [22]. Moreo-
ver, it has been demonstrated in different experimental
schemes that androstenedione has also a direct luteo-
tropic effect stimulating luteal progesterone production –
an effect not mediated by its previous conversion to estra-
diol – [23-25], and interfering with the programmed cell
death process that accompanies the regression of the cor-
pus luteum [25]. More recently, our laboratory demon-
strated that androstenedione can also indirectly exert a
luteotropic effect by regulating the activity of the celiac
ganglion [21].
In pregnant rats LH has a peculiar dual effect controlling
ovarian function. During the first half of pregnancy LH is
essential, together with prolactin, to sustain the corpus
luteum [22], whereas its increase in late pregnancy is det-
rimental for luteal function, promoting the regression of
the corpora lutea that accompanies parturition [26-28].
Considering the relevant role of androstenedione in rat
pregnancy and the fine modulatory control exerted by the
peripheral neural system throughout the celiac ganglion
on pregnant rat ovarian steroidogenesis, we set up to
study whether the celiac ganglion modulates, via the supe-
rior ovarian nerve, the anti-steroidogenic effect of LH in
late pregnant rats as assessed by measuring the production
of androstenedione by the ovary.
Materials and methods
Animals
Pregnant (day 0 = sperm positive) Holtzman rats were
used in the studies. They were housed under controlled
conditions of light (lights on 07:00 – 19:00 h) and tem-
perature (24 ± 2°C) with free access to standard rat chow
and water. Animals were handled in accordance with to
the procedures approved in the UFAW Handbook on the
Care and Management of Laboratory Animals [29]. The
experimental protocol was approved by the University of
San Luis Animal Care and Use Committee (ordinance CD
006/02).
Drugs
The following chemicals were purchased from Sigma
Chemical Co. (St. Louis, MO, USA): L-D-noradrenaline
hydrochloride (NA), dextrose, ascorbic acid, bovine
serum albumin fraction V (BSA), and luteinizing hor-
mone (LH). 1, 2, 6, 7-[3H] androst-4-ene-3, 17-dione
(115.0 Ci/mmol) was provided by New England Nuclear
Products (Boston, MA, USA). Other reagents were of ana-
lytical grade.
Experimental procedure
Groups of six animals on days 15, 19, 20 and 21 of preg-
nancy were used. They were anaesthetized and the celiac
ganglion-superior ovarian nerve-ovary system was
removed by dissection avoiding contact between the sur-
gical instruments and the nerve fibers, in order to prevent
spontaneous depolarization of the nerves. The piece of tis-
sue consisted of the left ovary, the fibers that constitutePage 2 of 9
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ment, and the celiac ganglion accompanied by some
small surrounding ganglia. The total surgical procedure
was completed in 1–2 min. In order to verify the existence
of the ganglion, routine histological techniques were fol-
lowed throughout the characterization of the system
(results not shown). Once the celiac ganglion-superior
ovarian nerve-ovary system was removed, it was cleaned
with incubation solution and placed immediately in a
cuvette with two compartments. Each compartment con-
tained 2 ml of buffer Krebs Ringer-bicarbonate pH 7.4,
with the addition of 0.1 mg/ml glucose and 0.1 mg/ml
albumin. The celiac ganglion was placed in one compart-
ment and the ovary in the other, connected by the supe-
rior ovarian nerve, which had to be kept moist with the
work solution (Figure 1). The system was stabilized by
preincubation in a metabolic bath at 37°C for 30 min
under a saturated O2/CO2 (95:5%) atmosphere. The end
of the pre-incubation period was considered as incuba-
tion time 0. At this time, the buffer was changed in both
compartments and 0.1 mg/ml ascorbic acid was added as
an antioxidant to the ganglion compartment (Control
group). For the experimental groups at incubation time =
0: 1) noradrenaline (10-6 M) was added in the ganglion
compartment (NA group); 2) on day 15 of pregnancy, LH
(50 ng/ml) was added in the ovarian compartment (Con-
trol-LH); 3) on day 15 of pregnancy, LH (50 ng/ml) was
added in the ovarian compartment and noradrenaline
(10-6 M) was added in the ganglion compartment (NA-LH
group). Periodic extractions were made from the ovarian
compartment at 30, 60, 120 and 180 min for determina-
tion of androstenedione and catecholamines (180 min)
released in the incubation media.
Hormone determination
The samples of liquid from the ovarian compartment
were stored at -20°C until hormone assay. Androstenedi-
one was measured by radioimmunoassay (RIA); the vari-
ability and cross-reaction of this RIA have been previously
reported [25]. The assay sensitivity was less than 10 pg/ml
androstenedione and the intra-assay coefficient of varia-
tion was less than 10.0%. The results were expressed as pg
of androstenedione per mg of ovarian tissue (A2 pg/mg
ovary) against time of incubation. The corresponding cor-
rections were made in all cases, taking into consideration
the volume extracted in each tested period.
Determination of catecholamines by HPLC
The catecholamines measured were dihydroxyphenyla-
lanine (DOPA), dopamine (DA), noradrenaline (NA) and
adrenaline (A). The catechols in 20 µl aliquots of liquid
from the ovarian cuvette (180 min) were partially purified
by batch alumina extraction, separated by reverse-phase
high-pressure liquid chromatography using a 4.6 mm ×
250 mm Zorbax RxC18 column (Du Pont, USA) and quan-
tified by current produced upon exposure of the column
effluent to oxidizing and then reducing potentials in series
using a triple-electrode system (Coulochem II, ESA, Bed-
ford, MA) [30]. Recovery through the alumina extraction
step averaged 70–80% for catecholamines and 45–55%
for DOPA. Catecholamine concentrations, in each sam-
ple, were corrected for recovery of an internal standard
dihydroxybenzylamine. Levels of DOPA were further cor-
rected for differences in recovery of the internal standard
and this catechol in a mixture of external standards. The
results were expressed as pg of catecholamine per mg of
ovarian tissue/180 min incubation (Catechol pg/mg
ovary/180 min incubation).
Statistical analysis
For multiple comparisons made along the time of incuba-
tion, repeated measures analysis of variance followed by
Tukey's test was used. Instead, for multiple comparisons
not involving repeated measures, one-way analysis of var-
iance followed by Tukey's test was utilized. A difference
was considered to be statistically significant at P < 0.05
[31].
Results
Effect of the addition of noradrenaline in the ganglion 
compartment on the levels of androstenedione 
accumulated in the ovarian compartment of celiac 
ganglion-superior ovarian nerve-ovary preparations 
obtained from animals sacrificed on days 19, 20, and 21 of 
pregnancy
The levels of androstenedione accumulated in the ovarian
compartment under basal conditions in the present stud-
ies were similar to those obtained previously in our labo-
ratory [20]. The addition of the adrenergic agonist
Schematic representation of the celiac ganglion-superior ovarian ne ve-ovary ex viv  incubation systemFigure 1
Schematic representation of the celiac ganglion-superior 
ovarian nerve-ovary ex vivo incubation system. NA, 
noradrenaline; CG, celiac ganglion; SON, superior ovarian 
nerve; OV, ovary; CAT, catecholamines; A2, androstenedi-
one.Page 3 of 9
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significant changes in the amount of androstenedione
accumulated in the ovarian compartment (Figure 2). In
tissue preparations obtained from day 19 pregnant ani-
mals, the addition of noradrenaline to the ganglion com-
partment led to an increase in androstenedione
accumulated in the ovarian compartment at 60 min incu-
bation (•p < 0.05) (Figure 2A). In preparations obtained
from day 20 pregnant animals, noradrenaline induced a
decrease in the amount of androstenedione accumulated
in the ovarian compartment at 180 min of incubation (*
p < 0.01) (Figure 2B). Finally, on day 21 of pregnancy
preparations, the presence of noradrenaline in the gan-
glion compartment caused a decrease in the levels of
androstenedione accumulated in the incubation media
when compared to controls along all times studied (* p <
0.01) (Figure 2C).
Effect of the addition of noradrenaline in the ganglion 
compartment and LH in the ovarian compartment on the 
levels of androstenedione accumulated in the ovarian 
compartment of celiac ganglion-superior ovarian nerve-
ovary preparations obtained on day 15 of pregnancy
When noradrenaline was added to the celiac ganglion
compartment of the celiac ganglion-superior ovarian
nerve-ovarian preparation obtained from day 15 pregnant
rats, the concentration of androstenedione accumulated
in the ovarian compartment decreased significantly at 120
min of incubation when compared to controls (• p <
0.05). In Control-LH group, the presence of LH (50 ng/
ml) in the ovarian compartment caused a significant
decrease in the amount of androstenedione accumulated
in the culture media at 180 min respect to 60 min (ap <
0.05). The presence of LH (50 ng/ml; Control-LH) in the
ovarian compartment caused a significant decrease in the
amount of androstenedione accumulated in the culture
media at 30, 120 and 180 min when compared to the lev-
els of androstenedione measured in the incubation media
of ovarian preparations not exposed to LH (b,c and d p <
0.05 vs. time-matched controls). The combined presence
of noradrenaline (10-6 M) in the ganglion compartment
and LH in the ovarian compartment decreased, up to 120
min, the levels of androstenedione accumulated in the
media when compared with incubation media of ovaries
stimulated with LH but without the presence of noradren-
aline in the ganglion compartment (NA-LH vs. Control-
LH) (30 and 60 min: * p < 0.01; 120 min: • p < 0.05). NA-
LH group decreased the levels of androstenedione at 30
min compared with the NA group e p < 0.01. (Figure 3).
Effect of the addition of noradrenaline in the ganglion 
compartment and LH in the ovarian compartment on the 
levels of catecholaminergic neurotransmitters released in 
the ovarian compartment of celiac ganglion-superior 
ovarian nerve-ovary preparations obtained on day 15 of 
pregnancy
The celiac ganglion-superior ovarian nerve-ovary system
obtained from 15-day pregnant rats was used to investi-
gate the presence of various catecholaminergic neuro-
transmitters in the ovarian incubation liquid. When
analyzing the levels of the neurotransmitters accumulated
up to 180 min of the system incubation, it was observed
that these levels were modified among the experimental
paradigms. In relation to dihydroxyphenylalanine
(DOPA) (Figure 4A), the highest levels were those
observed in the Control group. The presence of LH in the
ovarian compartment significantly decreased the concen-
tration of DOPA when compared to the control (Control-
LH vs. Control; a p < 0.01) and to the group receiving
noradrenaline in the celiac ganglion compartment (NA
group) (b p < 0.05). However, the simultaneous presence
of noradrenaline in the ganglion compartment signifi-
cantly prevented the decrease in DOPA accumulation
induced by LH (c p < 0.05), but without reaching the con-
trol levels (d p < 0.05). In Figure 4B, it can be observed that
the levels of dopamine (DA) in the ovarian compartment
increased significantly upon the combined addition of
noradrenaline in the ganglion compartment and LH in
the ovarian compartment (NA-LH group) when com-
pared to Control (a p < 0.05) and Control-LH (b p < 0.05)
groups. The only addition of noradrenaline in the celiac
ganglion or LH in the ovarian compartment did not show
significant differences in relation to the control levels. Fig-
ure 4C shows that the levels of noradrenaline are very low
in the Control group, in the group having noradrenaline
in the ganglion compartment (NA), and in the group
receiving LH in the ovarian compartment (Control-LH).
However, there was a remarkable increase in the amount
of noradrenaline accumulated in the media of the ovarian
compartment with the simultaneous presence of
noradrenaline in the ganglion compartment and LH in
the ovarian compartment (NA-LH) (a,b and c p < 0.01).
Figure 4D shows that adrenaline (A) was also present in
the ovarian incubation liquid, although at very low levels.
These levels were further decreased by the presence of LH
in the ovarian compartment (b p < 0.05). The addition of
noradrenaline in the ganglion compartment caused a
slight increase in the amount of adrenaline accumulated
in the ovarian compartment in relation to the Control and
the Control-LH groups (a and d p < 0.05), whereas the con-
current presence of LH in the ovarian compartment and
noradrenaline in the ganglion compartment led to a note-
worthy increase in the amount of adrenaline accumulated
in the ovarian compartment in relation the three previous
situations (c,e and f p < 0.01).Page 4 of 9
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Effect of noradrenaline (NA) in the ganglion compartment on the release of ovarian androstenedione (A2), using the celiac gan-glion-superior ovarian nerve-ovary system obtained from pregnant rats on days 19 (A), 20 (B) and 21 (CF gure 2
Effect of noradrenaline (NA) in the ganglion compartment on the release of ovarian androstenedione (A2), using the celiac gan-
glion-superior ovarian nerve-ovary system obtained from pregnant rats on days 19 (A), 20 (B) and 21 (C). The systems were 
incubated in Krebs-Ringer solution, at 37°C in an atmosphere of 95% O2-5% CO2 for 180 min. Ascorbic acid (0.1 mg/ml in 
Krebs-Ringer) without (Control) and with 10-6 M NA was added to the ganglionic compartment (NA groups). Results are 
expressed as mean ± S.E.M. of six animals per group. Repeated measures analysis of variance followed by Tukey's test was 
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The celiac ganglion-superior ovarian nerve-ovary system
utilized in this study provides an adequate ex vivo model
with good resemblance to the in vivo conditions, and
allows discerning endocrine-neural interactions about the
regulation of the physiology of the ovary. In the present
study, using this experimental approach, we present evi-
dence demonstrating that the capacity of the ovary of late
pregnant rats to produce androstenedione is modulated
by neural inputs coming from the celiac ganglion via the
superior ovarian nerve. This study also confirms that there
is a functional inter-relationship between the adrenergic
inputs on the celiac ganglion and the endocrine action of
LH in the ovary and that the response of the ovary to neu-
ral stimulation varies throughout pregnancy. Further-
more, these results contribute to the understanding of the
role of the peripheral nervous system in ovarian physiol-
ogy and can add to the understanding of certain patho-
logic states of reproduction that cannot be solely
explained by hormonal causes, such as polycystic ovary
syndrome, whose development is profoundly influenced
by the sympathetic nervous system [32].
In celiac ganglion-superior ovarian nerve-ovary prepara-
tions obtained on days 15, 19, and 20 of pregnancy
noradrenergic stimulation of the celiac ganglion did not
largely modify the capacity of the ovary to produce
androstenedione; however, there was a marked inhibition
in the capacity to accumulate androstenedione in the ova-
ries of preparations taken from day 21 pregnant rats that
had been subjected to noradrenergic stimulation of the
celiac ganglion. It is possible that ovaries of day 21 preg-
nant rats respond strongly to neural inputs because
androstenedione most probably originates in the intersti-
tial cells and the theca cells of growing preovulatory folli-
cles found in the ovary of rats at term [22] and that are
directly innervated by terminals from the superior ovarian
nerve [4]. The inhibitory effect of the noradrenergic stim-
ulation of the celiac ganglion on the androstenedione
producing capacity of late pregnant ovaries was further
visualized by the enhancement of the anti-steroidogenic
effect of LH. We have previously shown that adding LH to
the ovarian compartment of celiac ganglion-superior
ovarian nerve-ovary preparations obtained from day 15
pregnant rats did not affect progesterone production, yet
when combined with noradrenergic stimulation of the
celiac ganglion led to a decrease in the ovarian progester-
one producing capacity [17]. Overall results from the
present work and previous work in our laboratory [17]
demonstrate that the anti-steroidogenic effect of LH in
late pregnant rat ovaries is modulated by the activity of the
celiac ganglion. Whereas LH alone may be sufficient to
impair the capacity of the ovary to produce androstenedi-
one, it may need the contribution of neural inputs coming
from the celiac ganglion via the superior ovarian nerve to
also impair progesterone production.
The luteotropic effect of androstenedione in pregnant rats
has been widely demonstrated in different experimental
schemes [21,23,25]. Androstenedione appears to be a
potent tropic hormone that assists corpus luteum func-
tion particularly at the end of pregnancy when the gland
approaches its regression. This is supported by the fact
that when the ovary is populated with corpora lutea that
are approaching the time of regression (day 21 of preg-
nancy), they become more responsive to androstenedione
in terms of progesterone production in vivo and in vitro
[24]. Our current data show that ovaries taken at end of
pregnancy (day 21) are capable of producing more
androstenedione in vitro than ovaries obtained on previ-
Effect of noradrenaline (NA) in the celiac ganglion and LH in the ovary n th  production of ovarian androste edione (A2), using the c li c ganglion-SON-ovary system obtained from r ts ay 15 of preg a cyFigure 3
Effect of noradrenaline (NA) in the celiac ganglion and LH in 
the ovary on the production of ovarian androstenedione 
(A2), using the celiac ganglion-SON-ovary system obtained 
from rats on day 15 of pregnancy. The systems were incu-
bated in Krebs-Ringer solution, at 37°C in an atmosphere of 
95% O2-5% CO2 for 180 min. LH (50 ng/ml) was added to 
the ovarian compartment and ascorbic acid (0.1 mg/ml in 
Krebs-Ringer) without (Control-LH group) and with NA (10-
6 M) added to the ganglion compartment (NA-LH group). 
Control group was in absence of NA in the ganglion com-
partment and LH in the ovarian compartment. In the NA 
group, 10-6 M NA was added to the ganglionic compartment. 
Results are expressed as mean ± S.E.M. of six animals per 
group. Repeated measures analysis of variance followed by 
Tukey's test was used. The same font denote differences of 
statistical significance; ap < 0.05 between 60 and 180 min of 
Control-LH group; b,c and d p < 0.05 in Control-LH group 
compared with Control group; ep < 0.01 NA-LH group com-
pared with NA group.; *p < 0.01 and • p < 0.05 in NA-LH 
group compared with Control-LH group; • p < 0.05 in NA 
group compared with Control group.Page 6 of 9
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setting, it is possible that the ovarian production of
androstenedione needs to be limited in order to ensure
the regression of the corpus luteum. Neural inputs coming
from the celiac ganglion may be in charge of fine-tuning,
together with LH, the production of androstenedione at
the end of pregnancy.
In the current study we also provide evidence that four
metabolically related catecholamines (dihydroxyphenyla-
lanine, dopamine, noradrenaline and adrenaline) are
detected in the ovarian incubation compartment of the
celiac ganglion-superior ovarian nerve-ovary tissue prepa-
ration. The increase observed in the accumulation of
noradrenaline and adrenaline within the ovarian com-
partment upon the joint adrenergic stimulation of the
celiac ganglion and the endocrine ovarian effect of LH was
particularly dramatic, suggesting that they may be
involved in the anti-steroidogenic effect of LH at the end
of pregnancy in rats. It is not possible from our experi-
ments to know, however, the source or location of these
amines. LH may locally induce the release of catecho-
lamines either from: i) the nervous terminals coming
from the peripheral innervation (pool of catecholamines
synthesized in the celiac ganglion or in the superior ovar-
ian nerve terminals) [1]; ii) the intrinsic neurons of the
ovary (structures from a network of neurons developed as
a ganglion and located in the meso-ovarium and hilium
and neurons mostly isolated in the cortex and medulla)
[10]; or iii) a combination of both.
It was noticeable that the anti-steroidogenic effect of LH
on androstenedione production was associated with ele-
vated adrenaline and noradrenaline in the ovarian com-
partment; this observation is controversial because of the
fact that these two catecholamines have been usually
reported as favoring steroidogenesis [2]. It is possible that
any action of the catecholamines in the ovary in the pres-
ence of elevated concentrations of LH could be prevented
by a desensitizing effect of the gonadotropin in the cou-
pling of beta adrenergic receptors to adenylate cyclase
[33]. We should also consider that probably other neuro-
transmitters not analyzed in this work, such as NO
[34,35], GnRH [36,37] or neuropeptides such as NPY and
substance P (SP) [38] play roles together with catecho-
lamines in the neural control of the function of the ovary
during pregnancy; consequently they may mediate the
anti-steroidogenic effect of LH in the presence of elevated
catecholamines.
There is ample evidence suggesting that the sympathetic
nervous system is involved in pathologies associated to
the reproductive system. Evidence has been accumulating
supporting the participation of sympathetic nerves in the
function of the ovary under normal and pathological con-
ditions such as polycystic ovarian syndrome [32,39]. It is
overall suggested that chronic increase in ovarian sympa-
thetic nerve activity is related to changes in follicular
development, producing an anovulatory ovary with cysts,
but that the process can be reversed by attenuation of the
sympathetic activity [40]. Polycystic ovarian syndrome is
a common cause of infertility in women during their
reproductive years and is associated with cystic ovaries
and increased capacity to produce androgens. Whether a
dysregulation in the activity of the celiac ganglion and the
superior ovarian nerve is involved in the dysregulated
androgen production observed in polycystic ovary syn-
drome remains an attractive subject for future investiga-
tions. The results of the present study demonstrating that
adrenergic activation of the celiac ganglion impacts ovar-
ian androgen production in rats, certainly stimulates such
future investigations.
Conclusion
Our results demonstrate that in the ovary of late pregnant
rats the production of androstenedione is inhibited upon
the joint action of noradrenaline in the celiac ganglion
and LH in the ovary, and that this effect is associated with
marked changes in the release of catecholamines in the
ovary.
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Levels of catecholamines in the incubation liquid of the ovarian compartment at 180 min using the celiac ganglion-superior ovarian nerv -ovary system obtained fr m rats on day 15 of pregnancyFigure 4
Levels of catecholamines in the incubation liquid of the ovarian compartment at 180 min using the celiac ganglion-superior 
ovarian nerve-ovary system obtained from rats on day 15 of pregnancy. The systems were incubated in Krebs-Ringer solution, 
at 37°C in an atmosphere of 95% O2-5% CO2 for 180 min. LH (50 ng/ml) was added to the ovarian compartment and ascorbic 
acid (0.1 mg/ml in Krebs-Ringer) without (Control-LH group) and with NA (10-6 M) added to the ganglion compartment (NA-
LH group). Control group was in absence of NA in the ganglion compartment and LH in the ovarian compartment. NA group 
was in absence of LH in the ovarian compartment. Dihydroxyphenylalanine (DOPA), dopamine (DA), noradrenaline (NA), 
adrenaline (A). Results are expressed as mean ± S.E.M. of six animals per group. One-way analysis of variance followed by 
Tukey's test was used. Control, NA, Control-LH and NA-LH groups were compared. The same fonts denote differences of 
statistical significance.
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